Literature DB >> 28249081

Management of Type 2 Diabetes in 2017: Getting to Goal.

Jane E B Reusch1, JoAnn E Manson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28249081      PMCID： PMC5894353          DOI： 10.1001/jama.2017.0241

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Ralph A DeFronzo; Daniel Einhorn; Vivian A Fonseca; Jeffrey R Garber; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Robert R Henry; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2016-01       Impact factor: 3.443

2.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Authors:  Steven P Marso; Stephen C Bain; Agostino Consoli; Freddy G Eliaschewitz; Esteban Jódar; Lawrence A Leiter; Ildiko Lingvay; Julio Rosenstock; Jochen Seufert; Mark L Warren; Vincent Woo; Oluf Hansen; Anders G Holst; Jonas Pettersson; Tina Vilsbøll
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

4.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

5.  The Diabetes Educator and the Diabetes Self-management Education Engagement: The 2015 National Practice Survey.

Authors:  Dawn Sherr; Ruth D Lipman
Journal:  Diabetes Educ       Date:  2015-08-24       Impact factor: 2.140

6.  Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study.

Authors:  Sarah E Holden; Sara Jenkins-Jones; Craig J Currie
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

7.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
  7 in total
  35 in total

Review 1.  Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review.

Authors:  Salvatore Carbone; Dave L Dixon; Leo F Buckley; Antonio Abbate
Journal:  Mayo Clin Proc       Date:  2018-11       Impact factor: 7.616

2.  Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.

Authors:  Bruce E Landon; Alan M Zaslavsky; Jeffrey Souza; John Z Ayanian
Journal:  J Gen Intern Med       Date:  2018-02-09       Impact factor: 5.128

3.  Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

Authors:  Jinqiang Wang; Zejun Wang; Guojun Chen; Yanfang Wang; Tianyuan Ci; Hongjun Li; Xiangsheng Liu; Daojia Zhou; Anna R Kahkoska; Zhuxian Zhou; Huan Meng; John B Buse; Zhen Gu
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

4.  Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients.

Authors:  Huiyuan Hou; Takuhei Shoji; Linda M Zangwill; Sasan Moghimi; Luke J Saunders; Kyle Hasenstab; Elham Ghahari; Patricia Isabel C Manalastas; Tadamichi Akagi; Mark Christopher; Rafaella C Penteado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2018-02-13       Impact factor: 5.258

5.  Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.

Authors:  Jinqiang Wang; Jicheng Yu; Yuqi Zhang; Anna R Kahkoska; Zejun Wang; Jun Fang; Julian P Whitelegge; Song Li; John B Buse; Zhen Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

7.  Glycated hemoglobin: A powerful tool not used enough in primary care.

Authors:  Maria Salinas; Maite López-Garrigós; Emilio Flores; Carlos Leiva-Salinas
Journal:  J Clin Lab Anal       Date:  2017-08-30       Impact factor: 2.352

Review 8.  Cell Membrane Coating Nanotechnology.

Authors:  Ronnie H Fang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2018-03-27       Impact factor: 30.849

9.  Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus.

Authors:  Jie Li; Yanqin Huang; Sen Zhao; Qiuyue Guo; Jie Zhou; Wenjing Han; Yunsheng Xu
Journal:  Ann Transl Med       Date:  2019-11

10.  Use of diabetes medications in traditional Medicare and Medicare Advantage.

Authors:  Bruce E Landon; Alan M Zaslavsky; Jeffrey Souza; John Z Ayanian
Journal:  Am J Manag Care       Date:  2021-03-01       Impact factor: 2.229
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.